MEDP Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 1345 min ago

@ $394.44

Wydano: 30 bal. 2024 @ 18:52

Zwrot: -1.59%

Poprzedni sygnał: bal. 25 - 19:18

Poprzedni sygnał: Sprzedaż

Zwrot: 1.65 %

Live Chart Being Loaded With Signals

Commentary (1 geg. 2024 @ 17:17):

Stats
Dzisiejszy wolumen	24 460.00
Średni wolumen	284 201
Kapitalizacja rynkowa	12.03B
EPS	$0 ( 2024-04-22 )
Następna data zysków	( $2.50 ) 2024-07-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	39.65
ATR14	$7.29 (1.88%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Kraft Robert O.	Buy	72	Common Stock
2024-03-31	Kraft Robert O.	Sell	72	Restricted Stock Unit
2024-03-31	Mccarthy Cornelius P. Iii	Buy	63	Common Stock
2024-03-31	Mccarthy Cornelius P. Iii	Sell	63	Restricted Stock Unit
2024-03-31	Carley Brian T	Buy	79	Common Stock

INSIDER POWER
-94.48
Last 100 transactions
Buy: 69 002 \| Sell: 2 472 032

Wolumen Korelacja

Długi: 0.45 (neutral)

Krótki: -0.76 (moderate negative)

Signal:(41) Neutral

Medpace Holdings Inc Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Medpace Holdings Inc Korelacja - Waluta/Towar

-0.68
( moderate negative )

-0.84
( strong negative )

0.84
( strong )

-0.83
( strong negative )

0.63
( weak )

Medpace Holdings Inc Finanse

Annual	2023
Przychody:	$1.89B
Zysk brutto:	$524.51M (27.81 %)
EPS:	$9.20

FY	2023
Przychody:	$1.89B
Zysk brutto:	$524.51M (27.81 %)
EPS:	$9.20

FY	2022
Przychody:	$1.46B
Zysk brutto:	$432.44M (29.62 %)
EPS:	$7.57

FY	2021
Przychody:	$1.14B
Zysk brutto:	$328.16M (28.73 %)
EPS:	$5.08

Financial Reports:

No articles found.

Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.